Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2

• Autor(a) principal: Silva, Mariana Soares da
• Data de Publicação: 2021
• Outros Autores: Demoliner, Meriane, Hansen , Alana Witt, Gularte , Juliana Schons, Silveira, Flávio, Heldt, Fágner Henrique, Filippi, Micheli, Pereira, Vyctoria Malayhka de Abreu Góes, Silva, Francini Pereira da, Mallmann, Larissa, Fink, Pietra, Silva, Luana Letícia da, Weber , Matheus Nunes, Almeida, Paula Rodrigues de, Fleck, Juliane Deise, Spilki, Fernando Rosado
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Revista do Instituto de Medicina Tropical de São Paulo
• Texto Completo: https://www.revistas.usp.br/rimtsp/article/view/190210
• topic: Covid-19; Reinfection; SARS-CoV-2; P.1 lineage; Brazil

Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of the variant in Manaus, Northern Brazil. The same male patient was reinfected by another B.1.1.28 variant, namely P.2, in March, 2021. The genomic analysis confirmed genetically significant differences between the two viruses recovered in both infections, the P.1 lineage in the first episode and P.2 in the reinfection. Due the very early detection of P.1, we have also investigated the circulation of P.1 in the same region by differential RT-qPCR, showing that this was an isolated case of P.1 at the time of detection, and this variant has disseminated and became prominent from late January to the end of March, 2021. SARS-CoV-2 recent reports of reinfection have raised critical questions on whether and how well a first infection protects against reinfection.